NCT05848739 2025-05-11A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid TumorsSapience TherapeuticsPhase 1 Recruiting130 enrolled
NCT03251378 2024-09-25A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersHutchmedPhase 1 Completed129 enrolled 32 charts